The Trump administration is pushing pharmaceutical companies to begin negotiations to bring their drug prices in line with ...

Medicare recipients are facing unprecedented increases in their prescription drug costs, with some medications nearly tripling in price.

BATON ROUGE, La. (Louisiana Illuminator) - A low heat that’s simmered for weeks over an attempt to lower prescription drug prices in Louisiana increased to a boil Thursday in the waning hours of the ...

Federal agencies have scheduled a series of three web-based "listening sessions" to hear from commenters about issues that might be limiting competition in the U.S. prescription drug market and ...

In a victory for the pharmaceutical industry, a U.S. appeals court upheld a lower court decision to halt a controversial ...

The new law imposes restrictions and regulations on pharmacy benefit managers, or PBMs, that negotiate prescription drug prices between manufacturers, health insurance companies and pharmacies.

AbCellera Biologics' drug candidates in Phase 1 trials show promise, but financial losses and slow progress raise concerns.

More than 40 reports identify hospital rates and prescription drug prices as the main drivers of rising healthcare costs. But ...

ALEXANDRIA, VA / ACCESS Newswire / June 13, 2025 / The American Society of Consultant Pharmacists (ASCP) and the National Community Pharmacists Association (NCPA) have announced joint recommendations ...

Jubilant Pharmova shares rose after its board approved the slump sale of its API business to wholly-owned subsidiary, ...

UroGen Pharma's FDA nod for UGN-102 fuels recovery, but cash burn raises financing risks. Check out why I am maintaining my ...

Giving small-molecule drugs the same 13-year exemption from price negotiation as biologics would cost the federal government billions of dollars, argue three Harvard researchers ...